archive
| Events> | International Society for Cell and Gene Therapy of Cancer, Japan | 2006-10-13 |
 |
||
| Publications> | GenPhar's Trivalent Marburg Vaccine Proves 100% Protection, Virology, Fall 2006. | 2006-09-26 |
| Early data from GenPhar and USAMRIID's collaboration to develop a trivalent Marburg vaccine published in Virology's September 30, 2006 issue. | ||
|
||
| Events> | UBS Global Life Sciences Conference | 2006-09-25 |
|
||
| News> | GenPhar awarded $4 Million grant from National Institutes of Health | 2006-09-12 |
| NIH awarded GenPhar $4M to bring its trivalent Marburg vaccine into clinical development. | ||
|
||
| News> | GenPhar biodefense vaccines featured in Business section of Post and Courier newspaper | 2006-08-06 |
| GenPhar’s biodefense vaccines capture media attention and are featured in the article, “Firm at the forefront of bioterrorism fight.” The article highlights the socio-economic impact that GenPhar's Ebola, Marburg and other biodefense vaccines will have at the local, national and international level. | ||
|
||
| Events> | WilBio Asia-Pacific | 2006-06-26 |
| Dr. Dong presents on GenPhar's Vaccine Technology | ||
|
||
| Events> | SMI's Vaccine Conference | 2006-05-22 |
| Dr. Dong will present "The Development and Production of a Multivalent Vaccine" | ||
|
||
| Events> | Bio-Expo Japan | 2006-05-17 |
|
||
| News> | GenPhar holds pre-IND meeting for Ebola vaccine | 2006-05-15 |
| GenPhar held a pre-IND meeting for its Ebola vaccine May 12, 2006. The meeting with the FDA was successful and the company continues the drive towards human safety trials. GenPhar plans to file its Marburg vaccine in succession of the Ebola vaccine trials. | ||
|
||
| News> | GenPhar featured on WCIV ABC news | 2006-03-21 |
| GenPhar’s successful data from USAMRIID challenge experiments and contract extension with NMRC attracted local media attention. GenPhar was featured on four separate newscasts that focused on the company's biodefense Ebola, |
||
|
||
print this page
contact us
site map